PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Preventive Medicine & Public Health Research Center, Psychosocial Health Research Institute, Department of Community and Family Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.\', \'Antimicrobial Resistance Research Center, Department of Infectious Disease, School of Medicine, Hazrat-e Rasool General Hospital, Iran University of Medical Sciences, Tehran, Iran.\', \'Department of Virology, School of Medicine, Gastrointestinal and Liver Disease Research Center, Iran University of Medical Sciences, Tehran, Iran.\', \'Antimicrobial Resistance Research Center, Iran University of Medical Sciences, Tehran, Iran.\', \'Department of Infectious Disease, School of Medicine, Firoozgar General Hospital, Iran University of Medical Sciences, Tehran, Iran.\', \'Department of Community and Family Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.\', \'Department of Infectious Disease, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.\', \'Department of Infectious Disease, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. mitraranjbar@yahoo.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s12879-020-05698-w
?:hasPublicationType
?:journal
  • BMC infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 33317461
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.576
?:rankingScore_hIndex
  • 80
is ?:relation_isRelatedTo_publication of
?:title
  • Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all